vein-stenosed rats without affecting the degree of mes-The hemodynamic effects of long-term administration enteric-systemic shunts. (HEPATOLOGY 1996;23:537-543.) of octreotide in portal hypertension has not been established. In addition, whether long-term octreotide treatment prevents the developmen
Long-term administration of ddt or phenobarbital-na in wistar rats
✍ Scribed by Lorenzo Rossiz; Marina Ravera; Giuliana Repetti; Leonardo Santi
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 667 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In lifespan studies, outbred male and female Wistar rats were given either technical DDT mixed into the diet at a dose of 500 parts per million (ppm) or phenobarbital‐sodium dissolved in drinking water at a dose of 500 ppm. Liver‐cell tumors developed in treated animals but not in controls. The incidence of liver tumors was 45% in the DDT‐treated group and 44% in the phenobarbital‐sodium‐group. When evaluated by sex, DDT‐treated females and males had incidences of 56% and 35%, respectively, while in the phenobarbital‐sodium group, the respective incidences were 32% and 59% in females and males. These data show a varying susceptibility between the sexes, with regard to induction of liver‐cell tumors by the two compounds. In both treated groups, the number of nodular tumors per rat and the average size increased with age and were greater in females. None of these tumors had metastasized. Histologically, the liver tumors were nodular growths, which compressed surrounding parenchyma but did not infiltrate it. The total incidence of extrahepatic tumors was higher in controls than in treated animals. In this connection, we must mention the apparent, but not significant, reduction of adrenal tumors in treated rats compared to the controls.
📜 SIMILAR VOLUMES
Functional, biochemical and histological parameters of hepatotoxicity were assessed in male Sprague-Dawley rats receiving amiodarone (Am) short-term by gavage (5, 50, 150 and 500 mg Am kg-' day-', 10 days) or dietary exposure (50 ppm, 1500 ppm, 4-week duration), or by long-term dietary exposure (50